| Cash Flow | 2025-09-30 | 2025-06-30 |
|---|---|---|
| Other non-current assets | - | 0 |
| Net income attributable to the companys shareholders | 590,354 | 1,410,277 |
| Depreciation of property, plant and equipment | 595,360 | 397,436 |
| Amortization of right-of-use assets | 813,982 | 574,441 |
| Loss on disposal of property, plant and equipment | -142,045 | -142,045 |
| Reversal of impairment of property, plant and equipment | -87,392 | -87,392 |
| Loss on derecognition of rou assets | - | -77,060 |
| Gain on derecognition of rou assets | -77,060 | - |
| Provision for stock obsolescence of inventories | - | 283,214 |
| Allowance for stock obsolescence of inventories | 431,693 | - |
| Deferred income tax | -168,310 | -100,114 |
| Accounts receivable, net | -48,389 | -101,433 |
| Inventories, net | 446,049 | 732,054 |
| Prepayments and other current assets, net | 252,873 | 63,054 |
| Accounts payable | -1,273,736 | -293,898 |
| Operating lease liabilities | -554,143 | -384,235 |
| Income taxes payable | -5,805 | 329,364 |
| Amounts due to related parties | 942,178 | 1,572,807 |
| Advance from customers | 1,383,291 | 2,445,232 |
| Accrued expenses and other current liabilities | -768,148 | -740,566 |
| Net cash used in operating activities | -3,337,162 | -3,258,202 |
| Payment for the acquisition of subsidiary | - | 0 |
| Purchase of property, plant and equipment | 393,151 | 253,828 |
| Cash used in investing activities | -393,151 | -253,828 |
| Capital contribution | - | 0 |
| Deferred offering cost | 162,000 | 62,000 |
| Net cash used in financing activities | -162,000 | -62,000 |
| Net decrease in cash and cash equivalents | -3,892,313 | -3,574,030 |
| Cash and cash equivalents at beginning of period | 4,749,842 | 4,749,842 |
| Cash and cash equivalents at end of period | 857,529 | 1,175,812 |
Papa Medical Inc. (PAPA)
Papa Medical Inc. (PAPA)